Feed/Companies/Soley Therapeutics

Soley Therapeutics

As of 14 Oct 2026, Soley Therapeutics has raised $200M across 1 verified round on record; latest: $200 million Series C, announced 7 Jan 2026.

Soley Therapeutics is a biotech company that discovers and develops novel medicines by leveraging the sensing capabilities of human cells.

LATEST ROUND

Series C

$200M · 2026-01-07

RAISED ON RECORD · USD

$200M

across 1 verified round

INVESTORS

no lead named

SOURCES

from 2 publishers

Company

Every round on record, with the sources behind each and the investors on them.

Series C

$200M · 2026-01-07

[ HISTORY ]

lead not stated

Round	Amount	Announced	Lead	Buzz
Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$200M	2026-01-07	not stated	No recent discussion
2 sources [ VERIFIED · CORRECTED ] read against 2 sources HQ added South San Francisco · soleytherapeutics.com Surveyor Capital is described as the primary investor, not explicitly as lead; it is therefore listed among other investors.